CRIS - Strong Double BottomsRecurring Double Bottom patterns are evident
Once price completes its current double bottom 1.70 is a good target for price to aim for
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.81 USD
−47.41 M USD
10.02 M USD
7.47 M
About Curis, Inc.
Sector
Industry
CEO
James E. Dentzer
Website
Headquarters
Lexington
Founded
2000
FIGI
BBG000C1GTC9
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Cris Although it had nic rip off support of a larger pattern with another test of the mid term downward resiatnce I am looking to potentially scoop some up. I really want to see how we react at this 7.60$ level holding as support. Might be worth a buy attempt. Targets of 10$+ howver the Key breakout le
CRIS Primed for a reversalThe technicals are in favor for a bullish run. with a major gap to fill near 11.94. I think we see a positive run in the coming days
Big Winners For Monday 6/12/21 According To My AIThis is my top 10 estimates for the highs of the day on Monday (6/12/2021) according to my AI program and for those users that have been following my ai idea updates, I have improved the ai quite a bit to provide much more accurate results and I have implemented a scoring system that ranges from +30
CURIS STOCKIf we hold, we have a double bottom in play. This could lead to filling the gap that has occurred. Look for institutions to treat this as the Demand zone. The recent sell off was the supply zone.
CRIS - Daily chart analysisNot much to say about this. Prime example of what happens when top resistance breaks.
NO POSITION.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CRIS is 4.03 USD — it has decreased by −1.71% in the past 24 hours. Watch Curis, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Curis, Inc. stocks are traded under the ticker CRIS.
CRIS stock has risen by 1.26% compared to the previous week, the month change is a −25.09% fall, over the last year Curis, Inc. has showed a −55.37% decrease.
We've gathered analysts' opinions on Curis, Inc. future price: according to them, CRIS price has a max estimate of 26.00 USD and a min estimate of 18.00 USD. Watch CRIS chart and read a more detailed Curis, Inc. stock forecast: see what analysts think of Curis, Inc. and suggest that you do with its stocks.
CRIS reached its all-time high on Aug 1, 2000 with the price of 2,725.00 USD, and its all-time low was 3.51 USD and was reached on Nov 15, 2024. View more price dynamics on CRIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRIS stock is 10.56% volatile and has beta coefficient of 1.51. Track Curis, Inc. stock price on the chart and check out the list of the most volatile stocks — is Curis, Inc. there?
Today Curis, Inc. has the market capitalization of 34.12 M, it has increased by 3.80% over the last week.
Yes, you can track Curis, Inc. financials in yearly and quarterly reports right on TradingView.
Curis, Inc. is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
CRIS earnings for the last quarter are −1.70 USD per share, whereas the estimation was −1.83 USD resulting in a 7.10% surprise. The estimated earnings for the next quarter are −1.34 USD per share. See more details about Curis, Inc. earnings.
Curis, Inc. revenue for the last quarter amounts to 2.93 M USD, despite the estimated figure of 2.27 M USD. In the next quarter, revenue is expected to reach 2.20 M USD.
CRIS net income for the last quarter is −10.09 M USD, while the quarter before that showed −11.80 M USD of net income which accounts for 14.50% change. Track more Curis, Inc. financial stats to get the full picture.
No, CRIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 49.00 employees. See our rating of the largest employees — is Curis, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Curis, Inc. EBITDA is −47.14 M USD, and current EBITDA margin is −479.67%. See more stats in Curis, Inc. financial statements.
Like other stocks, CRIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Curis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Curis, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Curis, Inc. stock shows the sell signal. See more of Curis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.